Skip to main content

Advertisement

Log in

Disseminated Mycobacterial Disease in a Patient with 22q11.2 Deletion Syndrome: Case Report and Review of the Literature

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Davies EG. Immunodeficiency in DiGeorge syndrome and options for treating cases with complete athymia. Front Immunol. 2013;4:322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Davies EG, Cheung M, Gilmour K, Maimaris J, Curry J, Furmanski A, et al. Thymus transplantation for complete DiGeorge syndrome: European experience. J Allergy Clin Immunol. 2017;140:1660–70 e16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Yin SM, Ferdman RM, Wang L, Markert ML, Tam JS. Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. J Clin Immunol. 2015;35:435–8.

    Article  PubMed  Google Scholar 

  4. Agada NO, Yin SM, Tam JS, Kelly MS, Markert ML. Disseminated atypical mycobacterial infection in three patients with complete DiGeroge anomaly. J Allergy Clin Immunol. 2015;135:AB10.

    Article  Google Scholar 

  5. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26:454–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2018.

  7. Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, et al. Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3.

  8. Kong XF, Martinez-Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick EK, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Martinez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramirez-Alejo N, Mele F, et al. Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3:eaau6759.

    Article  PubMed  Google Scholar 

  10. Esteve-Sole A, Sologuren I, Martinez-Saavedra MT, Deya-Martinez A, Oleaga-Quintas C, Martinez-Barricarte R, et al. Laboratory evaluation of the IFN-gamma circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. Crit Rev Clin Lab Sci. 2018;55:184–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gambin T, Akdemir ZC, Yuan B, Gu S, Chiang T, Carvalho CMB, et al. Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort. Nucleic Acids Res. 2017;45:1633–48.

    CAS  PubMed  Google Scholar 

  12. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136:409–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M, et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015;349:606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the patient and his family who participated in the study.

Funding

This research was partially funded by Fondo de Desarrollo Científico y Tecnológico grant numbers 11181104 (for RH) and 1160858 (for AB). The Laboratory of Human Genetics of Infectious Diseases is supported by the National Institute of Allergy and Infectious Diseases grant number 5R37AI095983, the Rockefeller University, the St. Giles Foundation, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Descartes University, the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID) and the French National Research Agency under the “Investments for the future” program (grant number ANR-10-IAHU-01), ANR-GENMSMD (ANR-16-CE17-0005-01 for JB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arturo Borzutzky.

Ethics declarations

Approval for the study was obtained from the Scientific Ethics Committee, School of Medicine, Pontificia Universidad Católica de Chile. Informed consent was provided according to the Declaration of Helsinki.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoyos-Bachiloglu, R., Gallo, S., Vizcaya, C. et al. Disseminated Mycobacterial Disease in a Patient with 22q11.2 Deletion Syndrome: Case Report and Review of the Literature. J Clin Immunol 39, 743–746 (2019). https://doi.org/10.1007/s10875-019-00678-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-019-00678-5

Navigation